Table 2 Representative cell-penetrating peptides

From: Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines

Class

CPP name

Sequence

Origin

Ref.

Cationic

TAT (48-60)

GRKKRRQRRRPPQ

HIV-1 TAT

263

TAT (49-57)

RKKRRQRRR

HIV-1 TAT

263

Penetratin, pAntp (43-58)

RQIKIWFQNRRMKWKK

Antennapedia Drosophila melanogaster

263

Polyarginines

Rn

Chemically synthesized positively charged sequence

279

DPV1047

VKRGLKLRHVRPRVTRMDV

Chemically synthesized positively charged sequence

272

DP7

VQWRIRVAVIRK

Parent peptide HH2

762,763

Amphipathic

MPG

GALFLGFLGAAGSTMGA

A fusion sequence of HIV gp41 and NLS of SV40 T-antigen

281

Bac 7 (Bac 1-24)

RRIRPRPPRLPRPRPRPLPFPRPG

Bactenecin family of antimicrobial peptides

298

pVEC

LLIILRRRIRKQAHAHSK

Vascular endothelial cadherin

288

ARF (1-22)

MVRRFLVTLRIRRACGPPRVRV

the tumor suppressor protein p14ARF

289

CADY

GLWRALWRLLRSLWRLLWRA

Derived from PPTG1 peptide, W and charged amino acids

291,295

M918

MVTVLFRRLRIRRACGPPRVRV

the tumor suppressor protein p14ARF

289

BPrPr (1-28)

MVKSKIGSWILVLFVAMWSDVGLCKKRP

N terminus of unprocessed bovine prion protein

290

Pep-1

KETWWETWWTEWSQPKKKRKV

NLS from Simian Virus 40 large T antigen and reverse transcriptase of HIV-1

271

MAP

KLALKLALKALKAALKLA

Chemically synthesized amphipathic model peptide

292

VT5

DPKGDPKGVTVTVTVTVTGKGDPKPD

Chemically synthesized

764

Transportan

GWTLNSAGYLLGKINLKALAALAKKIL

Galanin-Lys-mastoparan

285

p28

LSTAADMQGVVTDGMASGLDKDYLKPDD

Azurin

286

Hydrophobic

C105Y

CSIPPEVKFNKPFVYLI

α1-Antitrypsin

305,306

PFV

PFVYLI

C105Y

307

Pep-7

SDLWEMMMVSLACQY

CHL8 peptide phage clone

305,306

  1. HIV Human Immunodeficiency Virus